शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEKrypton Industries Ltd· DiversifiedHighNeutral
Announced Fri, 30 May, 2025 · 19:18 IST

Outcome of Board Meeting pursuant to regulation 30 of SEBI LODR

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.4%Reaction day
₹52.73
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.5% vs market
Diversified peers, median of 11sector+0.0%-0.4% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.4 pts less than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.4+0.1-0.5+0.0-0.4
Next day
-2.4-0.2-2.2+0.7-3.1
2d
-4.4+0.3-4.7+0.4-4.7
3d
-6.3+0.9-7.1+0.5-6.8
4d
-8.1+0.8-8.9+0.5-8.7
5d
-5.7+2.2-7.8+1.1-6.7
1w
-8.5+3.4-11.9+2.9-11.4
15d
-11.1-0.8-10.3-0.8-10.3
1m
-13.7+2.9-16.6+0.3-14.0
2m
-11.5+0.8-12.3-0.1-11.4
3m
-14.1+0.0-14.1-4.6-9.5
UpDownMarket · Nifty Microcap 250Sector · Diversified peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Krypton Industries Ltd, at its meeting on May 30, 2025, approved the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, along with an unmodified (unqualified) audit opinion from P.K. Luharuka & Co. Standalone revenue from operations grew about 13% to Rs 4,683.55 lakhs (from Rs 4,137.37 lakhs), while standalone net profit declined roughly 14% to Rs 131.16 lakhs (from Rs 152.74 lakhs). Consolidated net profit fell more sharply to Rs 39.29 lakhs (from Rs 113.65 lakhs), dragged by the Hospital Equipments segment. The Board recommended a final dividend of Re 1 per share on a face value of Re 1, subject to shareholder approval. It also re-appointed Gulgulia & Associates as Internal Auditor, appointed Gyanendra Nahar & Co. as Secretarial Auditor for 5 years, and extended P.K. Luharuka & Co.'s term as Statutory Auditor by 2 more years (total 5-year tenure).

Likely market impact

Mixed signals for shareholders: topline growth was decent but bottomline contracted, especially on a consolidated basis, and finance costs rose sharply (Rs 239 lakhs vs Rs 162 lakhs). The 100% final dividend (Re 1 on Re 1 face value) is a positive return, and continuity of auditors and clean audit opinion provide some comfort, though the stock may react cautiously given the profit decline.